Longeveron LLC

/Longeveron LLC

We are a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions.


Price Range
$10.00 - $12.00

Final Shares

Anticipated Date
February 12, 2021


This offering is no longer available

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange